There is some concern that berberine's alteration of the gut microbiome may have other unknown health impacts, so many choose to use it for a limited time, usually less than six months at a time, to allow the gut to revert to baseline
Cost-Effectiveness Analysis Economic Burden of Pediatric Obesity The economic impact of pediatric obesity extends far beyond immediate healthcare costs
Every infusion is GP-prescribed, clinically delivered, and individually tailored, with clear protocols, screening, and follow-up to prioritise safety, precision, and personalised care
L.ZhangX.Oyler-CastrilloP.et al (2016)
Diabetol Metab Syndr 15 , 164 (2023)
The development of GLP-1 medications like Ozempic/Wegovy (semaglutide) and GIP/GLP-1 agonists like Mounjaro/Zepbound (tirzepatide) have been game changers when it comes to treating type 2 diabetes and obesity